# EQT Fund Management S.a r.l.: Form 13F holdings

An institutional investment manager in LUXEMBOURG. SEC CIK 1834239.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $862.6m
- Positions: 5 (5 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1834239/000119312526349398/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [WAYSTAR HLDG CORP (WAY)](/companies/way.md) | COM | $510.8m | 59.2% | 24,879,437 |  | Unchanged |
| PHARVARIS N V | COM | $118.4m | 13.7% | 3,424,609 |  | Unchanged |
| OCULIS HOLDING AG | ORDINARY SHARES | $96.4m | 11.2% | 6,950,294 |  | Added +1,050,000 |
| [EVOMMUNE INC (EVMN)](/companies/evmn.md) | COM SHS | $70.3m | 8.1% | 5,288,313 |  | Added +358,680 |
| [AGOMAB THERAPEUTICS NV (AGMB)](/companies/agmb.md) | SPONSORED ADS | $66.7m | 7.7% | 5,141,992 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-349398. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.